A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells (Q40404804)

20 September 2017

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells (English)

1 reference

20 September 2017

1

1 reference

20 September 2017

5

Cliona M Rooney

1 reference

20 September 2017

6

Malcolm K Brenner

1 reference

20 September 2017

4

Helen E Heslop

1 reference

20 September 2017

3

Gianpietro Dotti

1 reference

20 September 2017

2

Karin C Straathof

1 reference

20 September 2017

23 June 2005

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

5

1 reference

20 September 2017

933-941

1 reference

Haematopoietic cell transplantation as immunotherapy

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Molecules and mechanisms of the graft-versus-leukaemia effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Adoptive-cell-transfer therapy for the treatment of patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Treatment of Epstein-Barr virus-associated malignancies with specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Artificial T-cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

CD28/B7 costimulation: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Dual-specific T cells combine proliferation and antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

A critical role for OX40 in T cell-mediated immunopathology during lung viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

An inducible caspase 9 safety switch for T-cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.016

10.1016/J.YMTHE.2005.04.016

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

15979412